Dr. Grossman’s Blog

The Glaucoma Research Foundation (GRF) has received a gift of $1,550,000 from Melza and F.T. Barr, a GRF board member from Houston, to fund its new $12 million capital campaign in support of a comprehensive new strategic plan. The new capital campaign builds on the momentum of a three-year campaign completed in the summer of 2007, in which the goal of $7.5 million was met and exceeded. That campaign was originally motivated by the need to extend GRF’s Catalyst For a Cure research consortium into a second three-year cycle after its startup phase. Among the top objectives in the new strategic plan are the goal to reinforce GRF’s commitment to innovative research, emphasizing the need for the multi-year collaborations aimed at funding a cure; to seek partnerships with affiliate agencies to maximize patient resources and minimize duplication of efforts and offer wide distribution of these materials at minimal cost to eyecare professionals and their patients; and to continue the financial efficiency level that allows GRF to devote 85 cents of every dollar raised to research and patient education. For more information on the GRF, go to www.glaucoma.org. Also see our discussion of Glaucoma Treatment Options.